Lataa...
IL-2: The First Effective Immunotherapy for Human Cancer
The ability of IL-2 to expand T cells with maintenance of functional activity has been translated into the first reproducible effective human cancer immunotherapies. The administration of IL-2 can lead to durable, complete, and apparently curative regressions in patients with metastatic melanoma and...
Tallennettuna:
| Julkaisussa: | J Immunol |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6293462/ https://ncbi.nlm.nih.gov/pubmed/24907378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1490019 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|